Cigarette smoking-associated alterations in serotonin/adrenalin signaling pathways of platelets

Journal of the American Heart Association

Volumn 6, Issue 5, 2017, Pages

  Lowery, Curtis Lee ^a,b   Elliott, Clay ^a,b   Cooper, Anthonya ^a,b   Hadden, Coedy ^a,b   Sonon, Roberto N ^c   Azadi, Parastoo ^c   Williams, D Keith ^a   Marsh, James D ^a   Woulfe, Donna S ^d   Kilic, Fusun ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Department of Psychology   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Catecholamine; Circulation; Human; Receptor blocker; Serotonin; Smoking

Indexed keywords

CATECHOLAMINE; CATECHOLAMINE RECEPTOR; CD63 ANTIGEN; DOPAMINE; EPINEPHRINE; GLYCAN; GUANOSINE TRIPHOSPHATASE; NORADRENALIN; PADGEM PROTEIN; SEROTONIN; SEROTONIN TRANSPORTER; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; POLYSACCHARIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SEROTONIN 2 ANTAGONIST;

ACTIN FILAMENT; ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD SAMPLING; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CELL GRANULE; CELL MEMBRANE; CONTROLLED STUDY; DISSOCIATION RATE CONSTANT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; MORBIDITY; MORTALITY; NORMAL HUMAN; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; RISK FACTOR; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; SMOKING; TANDEM MASS SPECTROMETRY; THROMBOCYTE; THROMBOCYTE AGGREGATION; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PROTEIN TRANSPORT; THROMBOCYTE ACTIVATION; TIME FACTOR; UPREGULATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD PLATELETS; CALCIUM; CASE-CONTROL STUDIES; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPINEPHRINE; HUMANS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POLYSACCHARIDES; PROTEIN TRANSPORT; SEROTONIN; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS; TRANSGLUTAMINASES; UP-REGULATION;

EID: 85019354650     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.005465     Document Type: Article

References (50)

1. Nelson DE, Nelson DE, Kirkendall RS, Lawton RL, Chrismon JH, Merritt RK, Arday DA, Giovino GA. Surveillance for smoking-attributable mortality and years of potential life lost; by state-United States, 1990. MMWR CDC. 1994;43:1-8.
2. Anderson KM, Wilson PW, Odell PM, Kannel WD. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83:356-362.
3. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation. 2005;112:489-497.
4. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. Morb Mortal Wkly Rep. 2008;57:1226-1228.
5. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 1997;96:3243-3247.
6. Peterson DF, Coote JH, Gilbey MP, Futuro-Neto HA. Differential pattern of sympathetic outflow during upper airway stimulation with smoke. Am J Physiol. 1983;245:433-437.
7. Porchet HC, Benowitz NL, Sheiner LB, Copeland JR. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest. 1987;80:1466-1471.
8. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058-1066.
9. Siess W, Lorenz R, Roth P, Weber PC. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion. Circulation. 1982;66:44-48.
10. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F. Plasma serotonin levels and the platelet serotonin transporter. J Neurochem. 2007;102:206-215.
11. Grassi G, Grassi G, Seravalle G, Trevano FQ, Dell'oro R, Bolla G, Cuspidi C, Arenare F, Mancia G. Neurogenic abnormalities in masked hypertension. Hypertension. 2007;50:537-542.
12. Martin CA, McGrath BP. White-coat hypertension. Clin Exp Pharmacol Physiol. 2014;41:22-29.
13. Middlekauff HR, Park J, Agrawal H, Gornbein JA. Abnormal sympathetic nerve activity in women exposed to cigarette smoke: a potential mechanism to explain increased cardiac risk. Am J Physiol Heart Circ Physiol. 2013;305:1560-1567.
14. Woulfe DS. Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost. 2005;310:2193-2200.
15. Smyth SS, Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, Steinhubl SR, Becker RC. Gprotein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009;29:449-457.
16. Ziu E, Freyaldenhoven S, Mercado CP, Ahmed BA, Preeti P, Lensing S, Ware J, Kilic F. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol. 2012;52:1112-1121.
17. Fraer M, Kilic F. Serotonin: a different player in hypertension-induced thrombosis. AHA-Hypertension. 2015;65:942-948.
18. Millan MJ, Marin P, Bockaert J, Mannoury la Cour C. Signaling at G-proteincoupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci. 2008;29:454-464.
19. Dowal L, Flaumenhaft R. Targeting platelet G-protein coupled receptors (GPCRs): looking beyond conventional GPCR antagonism. Curr Vasc Pharmacol. 2010;8:140-154.
20. McNicol A, Israel SJ. Platelets and anti-platelet therapy. J Pharmacol Sci. 2003;93:381-396.
21. Mercado C, Ziu E, Kilic F. Communication between 5-HT and small GTPases. Curr Opin Pharmacol. 2011;11:23-28.
22. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alphagranule release. Cell. 2003;115:851-862.
23. Shirakawa R, Yoshioka A, Horiuchi H, Nishioka H, Tabuchi A, Kita T. Small GTPase Rab4 regulates Ca2+-induced alpha-granule secretion in platelets. J Biol Chem. 2000;275:33844-33849.
24. Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood. 2014;124:2013-2024.
25. Ahmed BA, Jeffus B, Harney JT, Bukhari IS, Unal R, Lupashin VV, van der Sluijs P, Kilic F. Serotonin transamidates Rab4 and facilitates binding to the C-terminus of hSERT. J Biol Chem. 2008;283:9388-9398.
26. Pittilo M. Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol. 2000;81:219-230.
27. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterialvasodilator function. J Circulation. 1995;92:1094-1100.
28. Li Y, Hadden C, Cooper A, Ahmed A, Wu H, Lupashin VV, Mayeux PR, Kilic F. Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability. Sci Rep. 2016;9:22747.
29. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367-1372.
30. Gu F, Derkach A, Freedman ND, Landi MT, Albanes D, Weinstein SJ, Mondul AM, Matthews CE, Guertin KA, Xiao Q, Zheng W, Shu XO, Sampson JN, Moore SC, Caporaso NE. Cigarette smoking behaviour and blood metabolomics. Int J Epidemiol 2016;45:1421-1432.
31. Mercado CP, Quintero MV, Li Y, Singh P, Byrd AK, Talabnin K, Ishihara M, Azadi P, Rusch NJ, Kuberan B, Maroteaux L, Kilic F. A serotonin-induced N-glycan switch regulates platelet aggregation. Sci Rep. 2013;30:2795.
32. Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995;25:1096-1105.
33. Anumula KR, Taylor PB. A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal Biochem. 1992;203:101-108.
34. Domon B, Costello CE. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry. 1998;27:1534-1543.
35. US Department of Health and Human Services. The health benefits of smoking cessation a report of the surgeon general. Atlanta: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS Publication No. (CDC) 90-8416.
36. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23:451-476.
37. Auerbach O, Garfinkel L. Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest. 1980;78:805-809.
38. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis. 1983;3:187-198.
39. US Department of Health and Human Services.The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
40. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997;50:307-364.
41. Mercado C, Kilic F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol Interventions. 2010;10:231-241.
42. Lee-Sundlov MM, Ashline DJ, Hanneman AJ, Grozovsky R, Reinhold VN, Hoffmeister KM, Lau JT. Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation. Glycobiology. 2017;27:188-198.
43. Wandall HH, Rumjantseva V, Sørensen AL, Patel-Hett S, Josefsson EC, Bennett EP, Italiano JE Jr, Clausen H, Hartwig JH, Hoffmeister KM. The origin and function of platelet glycosyltransferases. Blood. 2012;120:626-635.
44. Reinhard M, Jouvenal K, Tripier D, Walter U. Identification, purification, and characterization of a zyxinrelated protein that binds the focal adhesion and microfilament protein VASP (vasodilator-stimulated phosphoprotein). Proc Natl Acad Sci USA. 1995;92:7956-7960.
45. Giguere PM, Gall BJ, Ezekwe EA Jr, Laroche G, Buckley BK, Kebaier C, Wilson JE, Ting JP, Siderovski DP, Duncan JA. G Protein signaling modulator-3 inhibits the inflammasome activity of NLRP3. J Biol Chem. 2014;289:33245-33257.
46. Wallace SW, Magalhaes A, Hall A. The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells. Mol Cell Biol. 2011;31:81-91.
47. Matsuura K, Otani M, Takano M, Kadoyama K, Matsuyama S. The influence of chronic nicotine treatment on proteins expressed in the mouse hippocampus and cortex. Eur J Pharmacol. 2016;780:16-25.
48. Keularts IM, van Gorp RM, Feijge MA, Vuist WM, Heemskerk JW. a(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem. 2000;275:1763-1772.
49. Li M, Yu D, Williams KJ, Liu ML. Tobacco smoke induces the generation of procoagulant microvesicles from human monocyte/macrophages. Arterioscler Thromb Vasc Biol. 2010;30:1818-1824.
50. Badrnya S, Baumgartner R, Assinger A. Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost. 2014;112: 128-136.